CNX Therapeutics Ltd is a European speciality pharmaceutical company dedicated to improving patients' lives through a carefully curated portfolio of essential medicines, particularly in the fields of central nervous system (CNS) disorders, critical care, and other vital health areas. The company has experienced rapid expansion in recent years, driven by strategic acquisitions and partnerships, and now operates in over 60 markets worldwide. In addition to its commitment to delivering vital medicines to patients, CNX Therapeutics Ltd prioritises sustainability and ethical practices, ensuring that its operations benefit patients, employees, and the planet.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Finished Dosage Forms

As a key player in the pharmaceutical industry, CNX Therapeutics Ltd continues to enhance its service offerings and impact on patient care. For more information, please visit cnx-therapeutics.com.